In 2009, acquired an FDA and EU approved cGMP commercial manufacturing facility (oral dosage forms, 43,000 sf2) from Abbott at Edison NJ (~1 billion units annually).
GMP AREA
The facility passed eight FDA GMP inspections in June 2011, June 2012, December 2013, May 2016, June 2017, Jan. 2018, May 2018 and Jan. 2019.
